NM_000208.4:c.974+89C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000208.4(INSR):c.974+89C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 1,174,158 control chromosomes in the GnomAD database, including 20,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3267 hom., cov: 29)
Exomes 𝑓: 0.18 ( 17177 hom. )
Consequence
INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.756
Publications
10 publications found
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 19-7184227-G-A is Benign according to our data. Variant chr19-7184227-G-A is described in ClinVar as Benign. ClinVar VariationId is 1229895.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.974+89C>T | intron_variant | Intron 3 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.974+89C>T | intron_variant | Intron 3 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.974+89C>T | intron_variant | Intron 3 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.974+89C>T | intron_variant | Intron 3 of 20 | XP_011526291.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.974+89C>T | intron_variant | Intron 3 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.974+89C>T | intron_variant | Intron 3 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1 | n.949+89C>T | intron_variant | Intron 3 of 9 | 1 |
Frequencies
GnomAD3 genomes AF: 0.203 AC: 30745AN: 151476Hom.: 3252 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
30745
AN:
151476
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.179 AC: 183441AN: 1022564Hom.: 17177 AF XY: 0.180 AC XY: 93734AN XY: 520676 show subpopulations
GnomAD4 exome
AF:
AC:
183441
AN:
1022564
Hom.:
AF XY:
AC XY:
93734
AN XY:
520676
show subpopulations
African (AFR)
AF:
AC:
6498
AN:
24928
American (AMR)
AF:
AC:
8808
AN:
37814
Ashkenazi Jewish (ASJ)
AF:
AC:
4483
AN:
22834
East Asian (EAS)
AF:
AC:
4641
AN:
36382
South Asian (SAS)
AF:
AC:
16082
AN:
73482
European-Finnish (FIN)
AF:
AC:
8831
AN:
43376
Middle Eastern (MID)
AF:
AC:
590
AN:
3396
European-Non Finnish (NFE)
AF:
AC:
125032
AN:
734596
Other (OTH)
AF:
AC:
8476
AN:
45756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
7478
14957
22435
29914
37392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3762
7524
11286
15048
18810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.203 AC: 30803AN: 151594Hom.: 3267 Cov.: 29 AF XY: 0.206 AC XY: 15233AN XY: 74044 show subpopulations
GnomAD4 genome
AF:
AC:
30803
AN:
151594
Hom.:
Cov.:
29
AF XY:
AC XY:
15233
AN XY:
74044
show subpopulations
African (AFR)
AF:
AC:
10663
AN:
41302
American (AMR)
AF:
AC:
3209
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
AC:
683
AN:
3468
East Asian (EAS)
AF:
AC:
610
AN:
5164
South Asian (SAS)
AF:
AC:
1054
AN:
4806
European-Finnish (FIN)
AF:
AC:
2276
AN:
10468
Middle Eastern (MID)
AF:
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11709
AN:
67900
Other (OTH)
AF:
AC:
459
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1111
2223
3334
4446
5557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
653
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.